Richard E. Royal

19.6k total citations · 7 hit papers
100 papers, 11.1k citations indexed

About

Richard E. Royal is a scholar working on Oncology, Surgery and Immunology. According to data from OpenAlex, Richard E. Royal has authored 100 papers receiving a total of 11.1k indexed citations (citations by other indexed papers that have themselves been cited), including 52 papers in Oncology, 45 papers in Surgery and 28 papers in Immunology. Recurrent topics in Richard E. Royal's work include Intraperitoneal and Appendiceal Malignancies (33 papers), Immunotherapy and Immune Responses (23 papers) and Cancer Immunotherapy and Biomarkers (21 papers). Richard E. Royal is often cited by papers focused on Intraperitoneal and Appendiceal Malignancies (33 papers), Immunotherapy and Immune Responses (23 papers) and Cancer Immunotherapy and Biomarkers (21 papers). Richard E. Royal collaborates with scholars based in United States, Australia and Netherlands. Richard E. Royal's co-authors include Steven A. Rosenberg, Richard M. Sherry, Udai S. Kammula, Marybeth S. Hughes, James Chih‐Hsin Yang, Suzanne L. Topalian, Catherine Lévy, Sharon Mavroukakis, Nicholas P. Restifo and Donald E. White and has published in prestigious journals such as Science, Nature Medicine and The Journal of Experimental Medicine.

In The Last Decade

Richard E. Royal

97 papers receiving 10.9k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Cancer Regression in Patients After Transfer of Genetically Engineered Lymphocytes

2006 2.0k citations Richard A. Morgan, Mark E. Dudley et al. Science profile →
Adoptive Cell Therapy for Patients With Metastatic Melanoma: Evaluation of Intensive Myeloablative Chemoradiation Preparative Regimens

2008 1.0k citations Mark E. Dudley, James Chih‐Hsin Yang et al. Journal of Clinical Oncology profile →
Phase 2 Trial of Single Agent Ipilimumab (Anti-CTLA-4) for Locally Advanced or Metastatic Pancreatic Adenocarcinoma

2010 954 citations Richard E. Royal, Catherine Lévy et al. Journal of Immunotherapy profile →
Autoimmunity Correlates With Tumor Regression in Patients With Metastatic Melanoma Treated With Anti–Cytotoxic T-Lymphocyte Antigen-4

2005 771 citations Peter Attia, Ajay V. Maker et al. Journal of Clinical Oncology profile →
Enterocolitis in Patients With Cancer After Antibody Blockade of Cytotoxic T-Lymphocyte–Associated Antigen 4

2006 646 citations Joseph Blansfield, Khoi Q. Tran et al. Journal of Clinical Oncology profile →
Ipilimumab (Anti-CTLA4 Antibody) Causes Regression of Metastatic Renal Cell Cancer Associated With Enteritis and Hypophysitis

2007 537 citations James Chih‐Hsin Yang, Marybeth S. Hughes et al. Journal of Immunotherapy profile →
Prognostic Factors Related to Clinical Response in Patients with Metastatic Melanoma Treated by CTL-Associated Antigen-4 Blockade

2007 519 citations Jacob A. Klapper, Franz O. Smith et al. Clinical Cancer Research profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Richard E. Royal United States	39	8.1k	5.7k	2.3k	1.4k	1.3k	100	11.1k
Marybeth S. Hughes United States	31	11.4k 1.4×	7.7k 1.3×	2.9k 1.2×	2.4k 1.8×	749 0.6×	85	13.7k
Norbert Schmitz Germany	69	8.3k 1.0×	3.9k 0.7×	1.4k 0.6×	648 0.5×	414 0.3×	397	17.1k
Marco Bregni Italy	45	4.7k 0.6×	2.4k 0.4×	2.0k 0.8×	928 0.7×	523 0.4×	193	10.0k
Philippe Gaulard France	77	11.6k 1.4×	6.3k 1.1×	2.6k 1.1×	347 0.3×	1.2k 0.9×	383	23.0k
Wolfram Brugger Germany	51	4.7k 0.6×	3.7k 0.7×	2.9k 1.3×	446 0.3×	471 0.4×	191	10.6k
Stephen J. Schuster United States	48	8.3k 1.0×	2.9k 0.5×	1.7k 0.7×	1.1k 0.8×	385 0.3×	366	11.7k
Paul J. Kurtin United States	64	3.6k 0.4×	2.2k 0.4×	3.3k 1.4×	457 0.3×	942 0.7×	235	11.4k
Eric D. Hsi United States	62	4.7k 0.6×	2.6k 0.5×	3.2k 1.4×	389 0.3×	547 0.4×	405	12.2k
Adam Bagg United States	37	7.0k 0.9×	3.2k 0.6×	3.8k 1.6×	2.9k 2.1×	329 0.2×	216	11.9k
Hideto Tamura Japan	25	5.4k 0.7×	5.0k 0.9×	1.2k 0.5×	297 0.2×	428 0.3×	88	8.0k

Countries citing papers authored by Richard E. Royal

Since Specialization

Citations

This map shows the geographic impact of Richard E. Royal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Richard E. Royal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Richard E. Royal more than expected).

Fields of papers citing papers by Richard E. Royal

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Richard E. Royal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Richard E. Royal. The network helps show where Richard E. Royal may publish in the future.

Co-authorship network of co-authors of Richard E. Royal

This figure shows the co-authorship network connecting the top 25 collaborators of Richard E. Royal. A scholar is included among the top collaborators of Richard E. Royal based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Richard E. Royal. Richard E. Royal is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lucci, Anthony, Carolyn Hall, Sapna P. Patel, et al.. (2020). Circulating Tumor Cells and Early Relapse in Node-positive Melanoma. Clinical Cancer Research. 26(8). 1886–1895. 52 indexed citations

Snyder, Rebecca A., Keith F. Fournier, Richard E. Royal, Alan P. Venook, & George J. Chang. (2020). Heated Intraperitoneal Chemotherapy for Colorectal Carcinomatosis: Emerging Evidence. Clinical Colorectal Cancer. 19(1). 1–4.

Fisher, Sarah B., Ken Hess, Travis E. Grotz, et al.. (2017). Elevated brain natriuretic peptide (BNP) is an early marker for patients at risk for complications after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS + HIPEC). Journal of Surgical Oncology. 117(4). 685–691. 4 indexed citations

Sagebiel, Tara, Amr Mohamed, Aurelio Matamoros, et al.. (2017). Utility of Appendiceal Calcifications Detected on Computed Tomography as a Predictor for an Underlying Appendiceal Epithelial Neoplasm. Annals of Surgical Oncology. 24(12). 3667–3672. 10 indexed citations

Fang, Shenying, Yuling Wang, Yun Shin Chun, et al.. (2015). Association of Common Genetic Polymorphisms with Melanoma Patient IL-12p40 Blood Levels, Risk, and Outcomes. Journal of Investigative Dermatology. 135(9). 2266–2272. 5 indexed citations

Fang, Shenying, Yuling Wang, Yun Shin Chun, et al.. (2014). The relationship between blood IL‐12p40 level and melanoma progression. International Journal of Cancer. 136(8). 1874–1880. 4 indexed citations

Alexander, H. Richard, David L. Bartlett, James F. Pingpank, et al.. (2013). Treatment factors associated with long-term survival after cytoreductive surgery and regional chemotherapy for patients with malignant peritoneal mesothelioma. Surgery. 153(6). 779–786. 105 indexed citations

Rueth, Natasha M., Yan Xing, Yi-Ju Chiang, et al.. (2013). Is Surveillance Imaging Effective for Detecting Surgically Treatable Recurrences in Patients With Melanoma? A Comparative Analysis of Stage-Specific Surveillance Strategies. Annals of Surgery. 259(6). 1215–1222. 37 indexed citations

Lieu, Christopher H., Laura Lambert, Robert A. Wolff, et al.. (2011). Systemic chemotherapy and surgical cytoreduction for poorly differentiated and signet ring cell adenocarcinomas of the appendix. Annals of Oncology. 23(3). 652–658. 84 indexed citations

10.

Alexander, H. Richard, David L. Bartlett, Steven K. Libutti, et al.. (2009). Analysis of Factors Associated with Outcome in Patients Undergoing Isolated Hepatic Perfusion for Unresectable Liver Metastases from Colorectal Center. Annals of Surgical Oncology. 16(7). 1852–1859. 28 indexed citations

11.

Dudley, Mark E., James Chih‐Hsin Yang, Richard M. Sherry, et al.. (2008). Adoptive Cell Therapy for Patients With Metastatic Melanoma: Evaluation of Intensive Myeloablative Chemoradiation Preparative Regimens. Journal of Clinical Oncology. 26(32). 5233–5239. 1017 indexed citations breakdown →

12.

Yang, James Chih‐Hsin, Marybeth S. Hughes, Udai S. Kammula, et al.. (2007). Ipilimumab (Anti-CTLA4 Antibody) Causes Regression of Metastatic Renal Cell Cancer Associated With Enteritis and Hypophysitis. Journal of Immunotherapy. 30(8). 825–830. 537 indexed citations breakdown →

13.

Morgan, Richard A., Mark E. Dudley, John R. Wunderlich, et al.. (2006). Cancer Regression in Patients After Transfer of Genetically Engineered Lymphocytes. Science. 314(5796). 126–129. 1961 indexed citations breakdown →

14.

Blansfield, Joseph, Khoi Q. Tran, Andrew L. Feldman, et al.. (2006). Enterocolitis in Patients With Cancer After Antibody Blockade of Cytotoxic T-Lymphocyte–Associated Antigen 4. Journal of Clinical Oncology. 24(15). 2283–2289. 646 indexed citations breakdown →

15.

Rosenberg, Steven A., Richard M. Sherry, Kathleen E. Morton, et al.. (2006). Altered CD8+ T-Cell Responses When Immunizing With Multiepitope Peptide Vaccines. Journal of Immunotherapy. 29(2). 224–231. 28 indexed citations

16.

Maker, Ajay V., James Chih‐Hsin Yang, Richard M. Sherry, et al.. (2006). Intrapatient Dose Escalation of Anti–CTLA-4 Antibody in Patients With Metastatic Melanoma. Journal of Immunotherapy. 29(4). 455–463. 214 indexed citations

17.

Rosenberg, Steven A., Richard M. Sherry, Kathleen E. Morton, et al.. (2005). Tumor Progression Can Occur despite the Induction of Very High Levels of Self/Tumor Antigen-Specific CD8+ T Cells in Patients with Melanoma. The Journal of Immunology. 175(9). 6169–6176. 365 indexed citations

18.

Lapointe, Réjean, Richard E. Royal, Mark E. Reeves, et al.. (2001). Retrovirally Transduced Human Dendritic Cells Can Generate T Cells Recognizing Multiple MHC Class I and Class II Epitopes from the Melanoma Antigen Glycoprotein 100. The Journal of Immunology. 167(8). 4758–4764. 42 indexed citations

19.

Gannon, Christopher J., et al.. (2001). Advanced proximal colon cancer. Surgical Endoscopy. 16(3). 446–449. 9 indexed citations

20.

Ziegler, Moritz M., et al.. (1993). Extended Myectomy-Myotomy. Annals of Surgery. 218(4). 504–511. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact